Good outcome after rituximab treatment for a mixed warm and cold autoimmune haemolytic anaemia | Zendy

B. Granel | Zendy; P. Rossi | Zendy; F. Bernard | Zendy; Isabelle Dettori | Zendy; Régis Costello | Zendy; A.-L. Demoux | Zendy; D. Bagnères | Zendy; Pierre Lafforgue | Zendy; Y. Francès | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Good outcome after rituximab treatment for a mixed warm and cold autoimmune haemolytic anaemia

Author(s) -

B. Granel,

P. Rossi,

F. Bernard,

Isabelle Dettori,

Régis Costello,

A.-L. Demoux,

D. Bagnères,

Pierre Lafforgue,

Y. Francès

Publication year - 2009

Publication title -

bmj case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.231

H-Index - 26

ISSN - 1757-790X

DOI - 10.1136/bcr.09.2008.0857

Subject(s) - rituximab , medicine , mixed connective tissue disease , immunology , cold agglutinin disease , lymphoproliferative disorders , autoimmune disease , rheumatology , autoimmune hemolytic anemia , antibody , lymphoma

Mixed warm and cold autoimmune anaemia is a rare haemolytic anaemia that is commonly associated with lymphoproliferative disorders and autoimmune diseases. Although steroid therapy is the first-line treatment, rituximab represents a good alternative. The present study reports on a successful treatment with rituximab in a young woman suffering from a mixed warm and cold autoimmune haemolytic anaemia associated with a mixed connective tissue disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research